Navigation Links
Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
Date:3/4/2009

CENTER CITY, Minn., March 4 /PRNewswire-USNewswire/ -- The Johnson Institute has transferred key programs and products to the Hazelden Foundation Center for Public Advocacy under an agreement reached last week by the boards of both organizations.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO)

The transfer ensures a continuation of the Johnson Institute's formative 43-year history of promoting the power and possibility of recovery from alcoholism and dependence on other drugs.

It also bolsters Hazelden's mission to improve public awareness about addiction and expand access to treatment and recovery.

"We want to keep the Johnson Institute's legacy alive for future generations," said Mike Sime, the chair of JI's board of directors. "From the beginning, ours is a history intimately linked to Hazelden's, and with our programs and products we believe Hazelden will impact more people who need help and hope."

The Johnson Institute was founded in 1966 in Minnesota. In the decades since, millions of people have sought help through JI's innovative programming which emphasizes early intervention, family involvement and community support.

In 1998, the Johnson Institute sold more than 140 publishing products to Hazelden which since that time have been exclusively distributed by Hazelden in the marketplace with the joint imprint of the two organizations. There are products for individuals seeking recovery, their family members, schools, treatment centers, hospitals and civic organizations, among others.

"The Johnson Institute has pioneered many of the intervention and training tools used across the country today to help people find hope and healing from their problems," said Mark Mishek, Hazelden's president and CEO. "Hazelden is committed to further
'/>"/>

SOURCE Hazelden Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Authentidate Holding Corp. Non-executive Chairman F. Ross Johnson Steps Down From Board of Directors
2. Healthcare Businesswomens Association Names Johnson & Johnsons Alex Gorsky, Worldwide Chairman, Surgical Care, as the 2009 HBA Honorable Mentor
3. United States Joins Suits Against Scios and Johnson & Johnson
4. Johnson & Johnson Completes Acquisition of Mentor Corporation
5. Johnson & Johnson Completes Tender Offer for Mentor Corporation
6. SC Johnson Again a Best Place to Work in America
7. Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
8. Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered
9. Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation
10. Former Johnson & Johnson Executive Gives Big Voice to Small Companies
11. Johnson & Johnson to Review Fourth-Quarter and Full-Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...er thrill when on an emotional rollercoaster, stud... News) -- Call it the fear factor meets the jubila...tators -- especially those who root for the winnin...a closely contested match and victory was in doubt..., Chew on that this Thanksgiving weekend as you,r...
(Date:11/26/2009)... Benton Communications announces a highl...tem for retailers struggling to make an economic r...er 26, 2009 -- Flu fears is the type of challenge ...ncy room, according to Dr. David Benton, business ...iness growth system – The Rfactor Intensive...
(Date:11/25/2009)...LLE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPha...thecompanywillhosttwoinvestoreventsinDecember: ,...CT/10:00a.m.ET ,, Principalinvestigatorswilld...apsedand/orrefractorymultiplemyeloma,asfeaturedatt...gandExpositioninNewOrleans,LA.Theteleconferencewil...
(Date:11/25/2009)...PRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticle...ugEvaluationandResearch,titled"ADifficultBalance-P...v.26,2009issueofTheNewEnglandJournalofMedicine. ,...90824/FDALOGO ) ,, Inthearticle,Woodcockdiscuss...icationforthosewhoneeditandmanagingtherisksposedby...
(Date:11/25/2009)...vivors of testicular cancer who were treated with ...effects, including neurological side effects and R...ed with chemotherapy, according to a new study pub...ational Cancer Institute . , Marianne Brydy, M.D...sity Hospital, in Bergen, Norway, and colleagues c...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...Someday, DNA tests might spot those most at risk, ...Day News) -- Variations in two genes may help spur...y prescribed antidepressant, research suggests. , ...but dangerous side effect. , "These findings, if ...
...WARSAW, Ind., Sept. 27 As part of an industry-wid... manufacturers, DePuy,Orthopaedics, Inc. has enter...ey,s Office that resolves a previously reported go...istrict,of New Jersey. The agreement contains no ...
...BEDFORD, Mass., Sept. 27 Insulet Corporation,(Nas...Management System,today announced that it has been...om the Community Health Accreditation Program (CHA...g the quality of home and community-based health c...
...RESEARCH TRIANGLE PARK, N.C., Sept. 27 North Caro...optometry degree are,encouraged to attend the 2007... sponsored by the N.C. State Education Assistance ...ctober 8, 2007 North Carolina State University in ...
...Co-Chairs Are Reps. Berry, Moran, McMorris Rodgers...onal,Community Pharmacists Association (NCPA) toda...ongressional Community Pharmacy Coalition. The,Coa...alues these small business owners who often reside...
...Parents, confident children are protected when sho...ills 99%+ of bacteria on shopping carts, GREEN BA...Wis., is proud to be an iParenting Media Award Win...l were put,through the only internationally certif...
Other Medicine News:Health News:Genes Might Predispose Antidepressant Users to Suicidal Thoughts 2Health News:Genes Might Predispose Antidepressant Users to Suicidal Thoughts 3Health News:Statement of DePuy Orthopaedics, Inc. Regarding Agreement with U.S. Attorney's Office 2Health News:Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program 2Health News:Optometry Career Conferences Set for Five N.C. Campuses in October 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 3Health News:PureCart Systems of Green Bay, Wis., is an Honored Recipient of an iParenting Media Award 2
(Date:11/25/2009)...irstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicalde...disruptivesurgicaltreatmentsforthespine,announcedt...30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallw...heCompany,sproductsandwillincludecommentsfrommanag...ial-innumbersare1-877-407-4018fordomesticcallersan...
(Date:11/25/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...gDelivery-USMarketTrends&Analysis http://www....---US-Market-Trends--Analysis.html ,, TheUSint...therapeuticapplicationsfromthedeliveryofconvention...apeuticdrugs.Thefutureofthetechnologyhingesontothe...
(Date:11/25/2009)...RNewswire/-- ChemoCentryx,Inc.,announcedtodaythat...heProspectiveRandomizedOralTherapyEvaluationinCroh...ntswithmoderate-to-severeCrohn,sdiseasedemonstrate...typrofile.Thestudydemonstratedevidenceofclinicalef...0-pointdecreaseintheCrohn,sDiseaseActivityIndex(CD...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Tasty Foods Send Signal to Brain to Keep Eating 57329 1Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 1Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 2Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 3Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 4Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 1Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 2Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 3
...Thallion Pharmaceuticals Inc.,(TSX: TLN) announced...linical trial investigating ECO-4601 in advanced c...art of the American,Society of Clinical Oncology (...Phase I dose escalation portion of the study, 14,p... and one,glioma), that had completed and not respo...
...hich compares favorably with,the activity of mTOR ...wire-FirstCall/ - AEterna,Zentaris Inc. , a global...erapy and oncology, today announced that its partn...tlining Phase 1 and,Phase 2 results for perifosine...r compound, for the treatment of patients with,adv...
Other Medicine Technology:Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: